SCHEMBL1978722

SCHEMBL1978722

COc1cc(C(C)(C[N+](=O)[O-])C(C)=O)ccc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
MAPT P10636 4/20 0.37
RORC P51449 1/20 0.37
THRB P10828 1/20 0.36
LMNA P02545 3/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPK1 P28482 2/20 0.36
HTT P42858 1/20 0.36
FBP1 P09467 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713016 0.88 ALDH1A1 (0.46) ALDH1A1MEN1KMT2AL3MBTL1CYP1A2
SCHEMBL1978719 0.78 ALDH1A1 (0.39) ALDH1A1MAPTRORCTHRBLMNA
SCHEMBL10227971 0.76 KMO (0.43) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL602672 0.70 AKR1C3 (0.47) ALDH1A1MAPTLMNAHPGDCYP1A2
SCHEMBL15383148 0.69 CNR2 (0.48) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL10227980 0.69 RIPK2 (0.42) ALDH1A1MAPTLMNAHPGDCYP1A2
SCHEMBL10227970 0.69 RIPK2 (0.39) ALDH1A1MAPTLMNAHPGDCYP1A2
SCHEMBL179444 0.69 CYP2C19 (0.44) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL11844851 0.69 ALDH1A1 (0.41) ALDH1A1MAPTMEN1KMT2AMAPK1
SCHEMBL14862611 0.68 L3MBTL1 (0.43) ALDH1A1MAPTMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2509960-A1 TGR5 AGONISTS Exelixis, Inc. (US) 2012-10-17 EP disclosed
WO-2011071565-A1 TGR5 AGONISTS EXELIXIS, INC. (US) 2011-06-16 WO disclosed